CLDF Title
Contact Us | Bookmark
  HBV   HCC   HCV   HE   NASH   PBC   THROMBOCYTOPENIA
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
      IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Novo Nordisk and Gilead team up to test fatty liver disease treatment
04-12-2019
Clusters of autoimmune liver disease suggest environmental trigger
04-11-2019
US liver cancer deaths more common with less education
04-08-2019
Fecal microbiome signature detects cirrhosis in nonalcoholic fatty-liver disease
04-04-2019
More heart, lung transplants possible with therapy to clear Hep C from donor organs
04-03-2019
View Complete News Library
 
 
View all Congresses
 
 
 
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries
 
Impact of hepatitis C treatment on pain intensity, prescription opioid use and arthritis
 
Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
 
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs
 
Vitamin D deficiency and health-related quality of life in chronic hepatitis C
 
Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience
 
Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence
 
Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults
 
Efficacy and safety of megestrol in the management of hepatocellular carcinoma: a systematic review of the literature
 
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
 
Non-alcoholic fatty liver disease: prevalence and all-cause mortality according to sedentary behaviour and cardiorespiratory fitness. The HUNT Study
 
Identifying and Treating Nonalcoholic Fatty Liver Disease
 
Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
 
Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty LiverDisease Susceptibility: A Systematic Review and Meta-Analysis
 
Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans
 
Mini-review: end-points for drug treatment in NASH
 
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times
 
Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017
 
Hepatitis B: Screening, Prevention, Diagnosis, and Treatment
 
Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection
 
Screening and Treating Hepatitis C in the VA: Achieving Excellence Using Lean and System Redesign
 
Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center
 
 
Patterns and Predictors of Mortality after Waitlist Dropout of Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
 
Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma
 
Effect of Fish Oil Supplementation on Hepatic and Visceral Fat in Overweight Men: A Randomized Controlled Trial
 
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
 
Evidence of bias during liver transplant evaluation of nonalcoholic steatohepatitis cirrhosis patients
 
NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
 
Achieving Excellence in Hepatitis B Virus Care for Veterans in the Veterans Health Administration
 
Pelvic Floor Dysfunction in the Female Athlete
 
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology
 
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease
 
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis CVirus Genotype 1 or 4 Infection and Advanced Kidney Disease
 
Safety and Efficacy of Elbasvir/Grazoprevir in Asian Participants with Hepatitis CVirus Genotypes 1 and 4 Infection
 
Bridging the access gap: Medicare ineligibility in people living with chronic hepatitis B
 
Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses
 
A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
 
Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B
 
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
 
Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients
 
Integrating comprehensive hepatitis C virus care within a residential substance use disorder treatment program
 
Treating HCV Infection: It Doesn't Get Much Better Than This
 
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016
 
The HCV care continuum: linkage to HCV care and treatment among patients at an urban health network, Philadelphia, PA
 
 
Hepatitis C in Pregnancy: A Unique Opportunity to Improve the Hepatitis C Cascade of Care
 
Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care
 
The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science
 
Impact of Substance Use Disorder on the Rate of Sustained Virological Response in Veterans With Chronic Hepatitis C Treated With Direct-Acting Antivirals
 
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy
 
Efficacy and Safety of Ruzasvir 60 mg and Uprifosbuvir 450 mg for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection
 
National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States
 
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association with Outcomes: Single-Center Experience
 
Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?
 
Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes
 
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
 
Medical treatment of advanced hepatocellular carcinoma patients: the issue is not the right drug, but the right patient
 
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased ?-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
 
Regorafenib: a promising treatment for hepatocellular carcinoma
 
Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis
 
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
 
Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
 
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
 
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
 
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multi-Center Study
 
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability
 
 
          View All Abstracts  
  Line  
                               
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
OTHER
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.